The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Micky Tripathi, a top HHS official, said the election won’t impact AI regulations, despite fears that a Trump administration ...

STAT’s Matthew Herper picked Bristol Myers Squibb CEO Chris Boerner’s brain at the STAT Summit on all things related to the ...

On Thursday, Elevance Health disclosed in its third quarter earnings release that its medical loss ratio — the amount of ...

Alnylam's Yvonne Greenstreet, at #STATSummit, predicts vutrisiran will become multibillion-dollar product for ...

Because of race-based estimates, thousands of Black patients were placed further down kidney transplant waitlists.

The Senate report extensively cites STAT’s investigation of the use of algorithms and artificial intelligence within Medicare ...

Telehealth sites prescribing GLP-1s online can get off the ground in a matter of days by “renting” the services of these ...

The doctors said they lost control over their schedules, were told to prioritize coding patients’ illnesses, and felt like ...

Blue Note’s failure to clear the FDA hurdle offers a rare window into the regulatory challenges faced by digital therapeutics ...